Apteki 36.6 Financial Statements (APTK)
|
|
|
|
Report date
|
|
|
03.08.2023 |
03.08.2023 |
11.03.2024 |
24.03.2025 |
27.03.2026 |
|
27.03.2026 |
|
Currency
|
|
|
RUB |
RUB |
RUB |
RUB |
RUB |
|
RUB |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Presentation URL
|
|
|
|
|
|
|
|
|
|
|
|
Number of stores, pcs. |
|
|
|
|
|
2 554 |
|
|
|
|
New stores opened, pcs. |
|
|
|
|
|
403 |
|
|
|
|
Like for like sales, % |
? |
|
|
|
|
|
7.9% |
|
|
|
Online Sales, bln rub |
|
|
|
|
|
|
30.0 |
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
1.45 |
3.17 |
4.78 |
6.45 |
|
6.45 |
|
Operating Income, bln rub |
|
|
|
0.570 |
0.890 |
1.91 |
2.95 |
|
2.95 |
|
Net profit, bln rub |
? |
|
-1.49 |
-0.120 |
-0.001 |
0.115 |
0.044 |
|
0.044 |
|
|
OCF, bln rub |
? |
|
|
-3.36 |
-0.978 |
-3.32 |
-4.51 |
|
-4.51 |
|
CAPEX, bln rub |
? |
|
|
0.000 |
0.014 |
0.075 |
0.114 |
|
|
|
|
Ordinary share dividend yield, %
|
|
|
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
|
0.0% |
|
Dividend payout ratio, %
|
|
|
0% |
0% |
0% |
0% |
0% |
|
0 |
|
|
OPEX, bln rub |
|
|
|
0.761 |
2.16 |
2.71 |
3.36 |
|
3.36 |
|
Cost of production, bln rub |
|
|
0.000 |
0.120 |
0.126 |
0.161 |
0.136 |
|
0.136 |
|
Employment expenses, bln rub |
|
|
|
0.301 |
0.321 |
0.586 |
0.532 |
|
0.532 |
|
Interest expenses, bln rub |
|
|
|
3.57 |
3.04 |
5.44 |
7.31 |
|
7.31 |
|
|
Assets, bln rub |
|
|
76.1 |
76.3 |
77.0 |
78.2 |
79.4 |
|
79.4 |
|
Net Assets, bln rub |
? |
|
45.7 |
45.6 |
45.6 |
45.7 |
45.7 |
|
45.7 |
|
Debt, bln rub |
|
|
30.2 |
30.2 |
30.3 |
30.5 |
31.6 |
|
31.6 |
|
Cash, bln rub |
|
|
|
0.008 |
0.027 |
0.020 |
0.027 |
|
0.027 |
|
Net debt, bln rub |
|
|
30.2 |
30.2 |
30.3 |
30.4 |
31.6 |
|
31.6 |
|
|
Ordinary share price, rub |
|
|
14.0 |
11.6 |
14.2 |
11.5 |
8.49 |
|
6.47 |
|
Number of ordinary shares, mln |
|
|
2 331 |
2 331 |
7 630 |
7 630 |
7 630 |
|
7 630 |
|
Free Float, % |
|
|
|
|
|
|
6.00% |
|
6.00% |
|
|
Market cap, bln rub |
|
|
32.5 |
27.0 |
108.5 |
87.7 |
64.8 |
|
49.4 |
|
EV, bln rub |
? |
|
62.7 |
57.2 |
138.8 |
118.2 |
96.4 |
|
81.0 |
|
Book value, bln rub |
|
|
45.7 |
45.5 |
45.4 |
45.5 |
45.4 |
|
45.4 |
|
|
EPS, rub |
? |
|
-0.64 |
-0.05 |
0.00 |
0.02 |
0.01 |
|
0.01 |
|
FCF/share, rub |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0 |
|
BV/share, rub |
|
|
19.6 |
19.5 |
5.96 |
5.96 |
5.95 |
|
5.95 |
|
|
EBITDA margin, % |
? |
|
|
0.0% |
0.0% |
0.0% |
0.0% |
|
0 |
|
Net margin, % |
? |
|
|
-8.3% |
0.0% |
2.4% |
0.7% |
|
0.7% |
|
FCF yield, % |
? |
|
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
|
0.0% |
|
ROE, % |
? |
|
-3.3% |
-0.3% |
0.0% |
0.3% |
0.1% |
|
0.1% |
|
ROA, % |
? |
|
-2.0% |
-0.2% |
0.0% |
0.1% |
0.1% |
|
0.1% |
|
|
P/E |
? |
|
-21.8 |
-224.7 |
-108 505 |
762.9 |
1 472 |
|
1 122 |
|
P/S |
? |
|
|
18.6 |
34.2 |
18.4 |
10.0 |
|
7.66 |
|
P/BV |
? |
|
0.71 |
0.59 |
2.39 |
1.93 |
1.43 |
|
1.09 |
|
|
R&D/CAPEX, % |
|
|
|
|
0.00% |
0.00% |
0.00% |
|
|
|
|
CAPEX/Revenue, % |
|
|
|
0% |
0% |
2% |
2% |
|
0 |
|
| Apteki 36.6 shareholders |
